The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

Susumu Kobayashi on LinkedIn: #cancerresearch #cancertreatment

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

2022肺癌靶标热点追击，ERRα/LTK/EMSY初露锋芒-源井生物- 哔哩哔哩

LC-SCRUMによる新規非小細胞肺癌ドライバーの同定／ゲノム編集による治療を臓器特異的，病態特異的に届ける／コロナワクチン免疫の経時的な減衰

Nature：非小细胞肺癌新靶点CLIP1-LTK被发现，劳拉替尼效果不错@MedSci

Member Detail - DF/HCC

Oncogenic fusions in invasive mucinous LDAC. A, schematic

Frequency of driver mutations in lung adenocarcinoma A. and lung

Most frequently comutated genes with STK11 in non-small cell lung

Nature里程碑：非小细胞肺癌新靶点——CLIP1-LTK

Biomolecules, Free Full-Text